Previous Article | Next Article ![]()
Infection and Immunity, June 2007, p. 2655-2660, Vol. 75, No. 6
0019-9567/07/$08.00+0 doi:10.1128/IAI.01111-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands,1 Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands,2 Department of Infectious Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands3
Received 15 July 2006/ Returned for modification 23 September 2006/ Accepted 24 February 2007
|
|
|---|
|
|
|---|
The resistance of Salmonella serovar Typhimurium to host defense mechanisms increases as the lipopolysaccharide (LPS) chain length increases, i.e., from the lack of resistance of avirulent strains containing no or a very low number of sugars, so-called rough strains, to the high level of resistance of smooth, virulent bacteria containing a high number of sugars. Salmonella strains of the rough chemotype are susceptible to complement-mediated lysis, either in the presence or in the absence of antibody (23, 31), and are noninvasive after oral challenge (5, 25). Intracellular killing by human neutrophils is enhanced by complement activity, and the survival of Salmonella spp. in the presence of serum and neutrophils decreases as the LPS chain length shortens (31).
Neutrophils play an important role in the host defense against Salmonella (7). Neutrophils are equipped with various pattern recognition receptors, such as complement receptor 3 (CR3) (17), Dectin-1 (15), and several members of the Toll-like receptor (TLR) family (29). Together, these receptors enable the neutrophil to bind, phagocytose, and kill an array of pathogens without the need for the opsonization of these microorganisms. Two of these receptors, CR3 and TLR4, have been shown to interact with LPS (1, 35), one of the main components of the Salmonella outer membrane. Here, we investigated the role of CR3 and TLR4 in the killing of unopsonized Salmonella by neutrophils.
As a pattern recognition receptor, CR3 induces the uptake of a large variety of pathogens not covered by immunoglobulins or complement (14, 22). Furthermore, the spreading of Salmonella through the body in mice has been shown to be crucially dependent on the presence of CD18 (33). This phenomenon has been ascribed to the inability of CD18-deficient phagocytes to migrate through the different tissues, thereby limiting the spreading of the bacterium, since Salmonella species use phagocytes as a vector for their spreading. Since CR3 is important for the ingestion of different pathogens, we investigated the role of CR3 in the uptake of unopsonized Salmonella. Previously, different aspects of the opsonization by complement and the interaction with CR3 of opsonized Salmonella organisms have been investigated (11, 18). We found that, when Salmonella was incubated with neutrophils in the absence of serum, CR3 was the most essential component for its uptake.
Next, mutant-LPS, rough Salmonella bacteria were found to be less efficiently killed than the wild-type strain. Since LPS is also a well-known ligand for TLR4, a member of a family of receptors that has recently been shown to play an important role in the activation of the phagocyte NADPH oxidase (21), the role of TLR4 in NADPH oxidase activation was investigated. To confirm the involvement of TLR4 in the activation of the NADPH oxidase upon infection with wild-type Salmonella expressing full-length LPS, TLR4 signaling was inhibited with a TLR4-blocking, cell-permeable peptide. Furthermore, TLR4 was shown to signal from intracellular compartments under these conditions and did not recognize intact, unopsonized salmonellae in the extracellular milieu. In this study, we demonstrate that these two pattern recognition receptors, CR3 and TLR4, act sequentially in the uptake and killing of unopsonized Salmonella strains.
|
|
|---|
Intracellular killing of Salmonella. The survival of Salmonella organisms in neutrophils was determined as follows. Neutrophils were incubated in a 96-well plate at a concentration of 2.5 x 105 cells/well with 5 x 106 bacteria in HEPES medium. Bacterial phagocytosis was allowed to proceed for 15 min, and then gentamicin (100 µg/ml) was added. To determine Salmonella survival in neutrophils, the cells were incubated for another 45 min in the presence of gentamicin. Neutrophils were then washed three times with PBS and lysed by resuspension in distilled water. The survival of intracellular bacteria was determined by the method described by Rada et al. (26). For inhibition of the NADPH oxidase, neutrophils were pretreated with the NADPH oxidase inhibitor diphenylene iodonium (DPI) (6) at a final concentration of 20 µM for 30 min.
NADPH oxidase-mediated fluorescence of intracellular bacteria. Neutrophils were purified from heparinized blood as described previously, and experiments were performed with neutrophils from three healthy donors (28). Neutrophils (106) were incubated with 108 DHR-labeled bacteria of the different Salmonella strains at 37°C. At various time points, samples were taken and diluted 20 times in ice-cold PBS. After the last time point, all samples were centrifuged and resuspended in 100 µl of ice-cold PBS and analyzed by flow cytometry in a Becton Dickinson FACSStar (Palo Alto, CA).
Priming of ROS production of human neutrophils. Purified human neutrophils were primed at a concentration of 106 cells/ml in PBS containing 5.5 mM glucose and 0.5% (wt/vol) human albumin with either 20 ng/ml LPS, reextracted as previously described (16) (LPS from Salmonella serovar Typhimurium; Sigma, St. Louis, MO) in the presence of 1% (vol/vol) heat-inactivated human pool serum, 10 µg/ml Pam3CysSK4 (EMC Microcollections, Tübingen, Germany), or 500 ng/ml MALP-2 (EMC Microcollections) for 30 min at 37°C. Hydrogen peroxide production of purified human neutrophils after N-formyl-methionyl-leucyl-phenylalanine (fMLP; 10–6 M; Sigma) activation was measured by the Amplex Red assay (Molecular Probes) measured on a Perkin Elmer plate reader. For inhibition of Salmonella uptake by human neutrophils, these cells were preincubated with 10 µg/ml anti-CD18 (clone IB4; Ancell, Bayport, MN) for 15 min at room temperature.
CLS microscopy. Different Salmonella strains were labeled with Alexa 568 (Molecular Probes) according to the manufacturer's protocol. One million neutrophils were incubated with 108 labeled bacteria of the different Salmonella strains at 37°C. After 30 min, the cells were plated on glass coverslips coated with poly-L-lysine (100 µg/ml, 30 min, 37°C). The cells were allowed to adhere for 10 min and were then fixed with 3.7% (wt/vol) formaldehyde for 10 min at 4°C. The coverslips were then washed two times with PBS containing 0.2% (wt/vol) human serum albumin (HSA), and the cells were subsequently permeabilized with 0.1% (wt/vol) saponin. The cells were stained with a goat polyclonal antibody against TLR4 (clone sc-8694; Santa Cruz, Santa Cruz, CA) for 1 h in PBS-HSA. The coverslips were washed two times with PBS-HSA and subsequently incubated with Alexa 488-labeled rabbit anti-goat immunoglobulin G Fab2 fragments (Molecular Probes) for 1 h. The coverslips were washed three times with PBS-HSA and were then analyzed with a confocal laser scanning (CLS) microscope (Zeiss, Göttingen, Germany).
Cell-permeable peptides. To construct the TLR4-inhibiting cell-permeable peptide, the protein transduction domain of the human immunodeficiency virus protein Tat (30) (YARAAARQARAG) was coupled to the following amino acids: FKLCLHKRDFIPGKWI. As a control peptide, a peptide containing only the protein transduction domain was used (YARAAARRQARAG). Purified human neutrophils were preincubated with 200 µg/ml cell-permeable peptides for 1 min before the priming or Salmonella infection.
|
|
|---|
![]() View larger version (9K): [in a new window] |
FIG. 1. The uptake of unopsonized Salmonella is dependent on CR3 expression. Numbers of ingested Salmonella bacteria, opsonized or unopsonized, by human neutrophils were determined for control neutrophils and for neutrophils pretreated with the MAb 44a or with the MAb IB4. Also, neutrophils from an LAD-1 patient were included in this experiment. Numbers of ingested bacteria are represented as percentages of the number of bacteria taken up by control neutrophils. Values are means from three experiments (± standard deviations) performed in duplicate. *, P < 0.01 (compared to values for the control; analysis by Student's t test).
|
![]() View larger version (10K): [in a new window] |
FIG. 2. Numbers of CFU of viable intracellular wild-type, smooth Salmonella serovar Typhimurium and its rough (Ra) chemotype within neutrophils 1 h after taking up nonopsonized bacteria in the absence of serum. To inhibit NADPH oxidase activity, neutrophils were pretreated with 20 µM DPI. Values are means from three experiments (± standard deviations) performed in duplicate. *, P < 0.01 (compared to values for untreated bacteria; analysis by Student's t test).
|
To further investigate the activation of the NADPH oxidase after ingestion of Salmonella, wild-type and rough bacteria were labeled with DHR, a dye that is converted to the fluorescent product rhodamine-1,2,3 in the presence of hydrogen peroxide and a peroxidase (32). Labeling of Salmonella serovar Typhimurium with DHR did not alter the uptake, viability, or killing of these bacteria (data not shown). After being labeled, the bacteria were allowed to be ingested by neutrophils under serum-free conditions, and the fluorescence of both wild-type and rough Salmonella serovar Typhimurium strains inside the neutrophils was assayed at fixed times by flow cytometry (Fig. 3). Neutrophils infected by wild-type bacteria displayed a fluorescence signal that appeared after 30 min of infection and was maximal at 45 min. With the rough-strain-infected cells, the observed fluorescence was much lower than that for the wild-type-infected cells, indicating that the ROS production by neutrophils infected with the rough strain is much lower than that for the wild-type strain (Fig. 3). The rates of uptake and the kinetics of both strains were similar, as determined by counting the number of intracellular Salmonella bacteria over time after May-Grünwald-Giemsa staining (approximately 2.4 bacteria per cell at 45 min under the conditions used [data not shown]). Moreover, the observed differences in fluorescence were not due to different degrees of DHR labeling of the two strains, since phorbol myristate acetate stimulation, resulting in vigorous NADPH oxidase activation and the conversion of all DHR present on the bacteria into rhodamine, produced equal levels of fluorescence of wild-type- and rough-strain-infected neutrophils (Fig. 3). Together, these data show that at equal rates of uptake, wild-type Salmonella encounters more ROS after the uptake of human neutrophils than does an LPS mutant strain, which is a strong indication that LPS-mediated signaling contributes to NADPH oxidase activation.
![]() View larger version (12K): [in a new window] |
FIG. 3. Kinetics of hydrogen peroxide production by human neutrophils induced by infection with nonopsonized wild-type (WT) and rough Salmonella bacteria in the absence of serum. Values are means from three experiments (± standard deviations) performed in duplicate. *, P < 0.01 (compared to values for the wild type; analysis by Student's t test). MFI, mean fluorescence intensity.
|
Therefore, priming experiments with intact, smooth Salmonella bacteria were undertaken to determine whether any TLR signaling from the cell surface occurred under the conditions of the infection experiments, i.e., without the addition of serum. The recognition of LPS by TLR4/CD14 depends on the presence of LPS-binding protein (LBP), which is usually provided by the addition of serum but was not present in our system. The uptake of Salmonella was prevented by blocking CR3 (CD11b/CD18) with the inhibitory CD18 MAb IB4 (the efficacy of the inhibition of bacterial uptake was tested in this assay and was found to be identical to the inhibition shown in Fig. 1 [data not shown]). Clearly, intact bacteria did not prime the respiratory burst induced by fMLP under the conditions used for the infection experiments (Fig. 4). However, when recombinant LBP was added to the system, neutrophils were primed to an extent similar to that with purified LPS (Fig. 4). These results strongly suggest that in the absence of serum, intact Salmonella bacteria do not trigger TLR signaling on the cell surfaces of human neutrophils.
![]() View larger version (11K): [in a new window] |
FIG. 4. Priming of human neutrophils by intact, unlabeled bacteria. Hydrogen peroxide production by neutrophils was induced by 1 µM fMLP stimulation after the neutrophils were primed with LPS or intact smooth Salmonella bacteria in the presence or absence of recombinant LBP. Bacterial uptake was prevented by the blockade of CR3 (CD11b/CD18) by MAb IB4 (CD18). Values are means from three experiments (± standard deviations) performed in duplicate. *, P < 0.01 (compared to values for unstimulated bacteria; analysis by Student's t test).
|
![]() View larger version (14K): [in a new window] |
FIG. 5. Localization of TLR4 in wild-type- and rough-Salmonella-infected neutrophils. TLR4 localization in wild-type (A)- and rough (B)-Salmonella-infected neutrophils was examined by CLS microscopy 40 min after infection. Arrowheads indicate intracellular Alexa 568-stained Salmonella cells.
|
![]() View larger version (20K): [in a new window] |
FIG. 6. Inhibition of ROS production by a TLR4-specific, cell-permeable peptide. (A) Hydrogen peroxide production by neutrophils upon 1 µM fMLP stimulation after they were primed with different TLR ligands (Pam3CysSK4 for TLR1/2, MALP-2 for TLR2/6, LPS for TLR4, and nonopsonized zymosan for TLR2). RFU, relative fluorescence intensity. (B) Effect of TLR4-blocking peptide (200 µg/ml) and inhibitors of p38MAPK (SB20358, 10 µg/ml), pERK (U0126, 10 µg/ml), and phospholipase D (ethanol, 1%) on intracellular hydrogen peroxide production after Salmonella infection. Values are means from three experiments (± standard deviations) performed in duplicate. *, P < 0.01 (compared to values for the control peptide); **, P < 0.01 (compared to values for untreated bacteria; analysis by Student's t test). Contr, control.
|
|
|
|---|
The survival of the wild-type Salmonella cells was enhanced by inhibiting the activity of the NADPH oxidase. In contrast, the survival of the rough Salmonella cells was not affected when NADPH oxidase activity was inhibited. Taken together, these data suggest that NADPH oxidase is efficiently activated only by wild-type bacteria. Furthermore, the data imply that, aside from the NADPH oxidase, other antimicrobial systems are activated, since the survival of wild-type Salmonella was not increased to the level of rough Salmonella when NADPH oxidase activity was inhibited (Fig. 2).
By using DHR-labeled Salmonella, we found that, indeed, the NADPH oxidase is activated more potently by wild-type Salmonella than by rough Salmonella. Since TLR4 is able to recognize LPS, which can prime neutrophils to secrete ROS, we anticipated that differences in TLR4 signaling in infected neutrophils would lead to the observed differences in the levels of NADPH oxidase activity and killing of wild-type Salmonella and rough Salmonella strains. This possibility is supported by the fact that the efficient signaling of Salmonella LPS via human TLR4 critically depends on both the lipid A part and the sugar moieties of the LPS (24). This is in contrast to LPSs from most commonly used bacteria, such as Escherichia coli, of which the lipid A part alone is already sufficient to trigger TLR4 activation (24).
Moreover, extracellular intact bacteria, whose uptake was prevented by a CD18-blocking MAb, were not able to prime the activation of the NADPH oxidase in the absence of serum. Therefore, we conclude that the detection of LPS by TLR4 occurs intracellularly. In support of this notion, Salmonella-containing vacuoles, containing either wild-type or rough Salmonella bacteria, were found to colocalize with TLR4, which is consistent with previous reports (3). The identical localizations of TLR4 in wild-type- and rough-Salmonella-infected neutrophils strongly suggest that the routing of intracellular TLR4 to the Salmonella-containing vacuoles is the same under these conditions and that correct intracellular localization of TLR4 does not require activation via this receptor. Unlike with TLR4's correct localization, the subsequent triggering and the killing efficiency of the neutrophil strongly depend on the subsequent recognition of wild-type Salmonella LPS as a proper ligand. It remains unknown whether the recognition of intracellular Salmonella depends on (i) the presence of LBP, which was not added in our system but may be provided by the neutrophil itself, and (ii) the surface expression of CD14. If LBP is not provided by the neutrophil, this means that LPS, once intracellular, is recognized in a manner different from that at the cell surface but still via TLR4. The latter possibility is consistent with the recent findings on the requirement of CD14 as the coreceptor for smooth LPS, whereas TLR4 is able to recognize rough LPS in a CD14-independent fashion (10, 19).
To inhibit the intracellular activation of TLR4, a cell-permeable inhibitory peptide that specifically blocks TLR4 was used. The cell-permeable peptide potently inhibited NADPH oxidase activation in response to infection with wild-type Salmonella. This proves that the efficient activation of the NADPH oxidase by Salmonella LPS requires TLR4 signaling and that this activation occurs from Salmonella-containing vacuoles within the neutrophil. These results are consistent with a recent report by Laroux et al. (21), who described the essential role of MyD88, one of the most important adapter molecules in TLR signaling, in NADPH oxidase activation after the uptake of gram-negative bacteria, including Salmonella.
Overall, our study shows that at least CR3 and TLR4 are required for the efficient uptake of unopsonized Salmonella and the subsequent activation of NADPH oxidase in response to this pathogen. At present, it is unknown whether TLR4 is recruited from intracellular stores or is internalized from the plasma membrane during the uptake of the bacterium.
Published ahead of print on 12 March 2007. ![]()
|
|
|---|
, Z. Rìháková, B. Hofmanová, I.
plíchal, and B. Cukrowska. 1997. Pathogenicity and protective effect of rough mutants of Salmonella species in germ-free piglets. Infect. Immun. 65:5238-5243.[Abstract]
B through human Toll-like receptor 4. Infect. Immun. 70:6043-6047.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»